Literature DB >> 13106720

Streptokinase-streptodornase therapy of sterile postpneumonic empyema of long standing.

E ROSEN.   

Abstract

Entities:  

Keywords:  EMPYEMA, PLEURAL/therapy; STREPTODORNASE AND STREPTOKINASE/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13106720      PMCID： PMC1521910     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


× No keyword cloud information.
  5 in total

1.  THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

Authors:  W S Tillett; S Sherry
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

2.  Clinical experience with streptokinase and streptodornase.

Authors:  J M MILLER; M GINSBERG; R J LIPIN; P H LONG
Journal:  J Am Med Assoc       Date:  1951-03-03

3.  The use of streptokinase-streptodornase in the treatment of postneumonic empyema.

Authors:  W S TILLETT; S SHERRY; C T READ
Journal:  J Thorac Surg       Date:  1951-03

4.  Streptococcal enzymatic debridement.

Authors:  W S TILLETT; S SHERRY
Journal:  Ann Surg       Date:  1950-01       Impact factor: 12.969

5.  Unusual reaction to intrapleural administration of streptokinase and streptodornase.

Authors:  G L BAUM; P ORANSKY
Journal:  J Am Med Assoc       Date:  1952-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.